Apyx Medical Corporation (APYX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Apyx Medical Corporation (APYX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.44

-0.05 (-3.36%)

At close: Jan 14, 2025, 3:58 PM

1.48

2.78%

After-hours Jan 14, 2025, 04:46 PM EST

undefined% (undefined)

Bid	1.2
Market Cap	54.21M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.82
PE Ratio (ttm)	-1.76
Forward PE	n/a
Analyst	Hold

Ask	1.76
Volume	16,203
Avg. Volume (20D)	62,118
Open	1.48
Previous Close	1.49
Day's Range	1.42 - 1.56
52-Week Range	0.97 - 2.80
Beta	undefined

About APYX

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded ...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jan 2, 2019

Employees 252

Stock Exchange NASDAQ

Ticker Symbol APYX

Website https://www.apyxmedical.com

Analyst Forecast

According to 3 analyst ratings, the average rating for APYX stock is "Hold." The 12-month stock price forecast is $5, which is an increase of 247.22% from the latest price.

Buy 33.33%

Hold 66.67%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Apyx Medical Corporation is scheduled to release its earnings on Mar 20, 2025, before market opens.
Analysts project revenue of $13.02M, reflecting a -11.2% YoY shrinking and earnings per share of -0.16, making a -42.86% decrease YoY.

Why Price Moved

2 months ago · Source

+24.59%

Apyx Medical shares are trading higher after the c... Unlock content with Pro Subscription

9 months ago · Source

-28.65%

Apyx Medical shares are trading lower following soft FY24 guidance.

News

2 months ago · seekingalpha.com

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Apyx Medical Corporation (NASDAQ:APYX ) Q3 2024 Earnings Call Transcript November 8, 2024 8:00 AM ET Company Participants Jeremy Feffer - MD, LifeSci Advisors Stavros Vizirgianakis - Executive Chairma...

2 months ago · zacks.com

Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates

Apyx Medical (APYX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.13 per share a year ago.